R-ESHAP PROTOKOLÜ

Kaynaklar:

1-Aparicio J. ESHAP is an effective regimen for relapsing Hodgkin's disease. Ann Oncol 1999;10:593-5. 

2-Choi CW, Paek CW, Seo JH, et al. ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma. J Korean Med Sci. 2002 Oct;17(5):621-4. 

3-Park SH, Kim S, Ko OB, et al. ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience. Korean J Intern Med. 2006 Sep;21(3):159-64. 

4-Velasquez WS, Cabanillas FC, Velasquez W, et al. Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP . J Clin Oncol 1995;13:1734-41. 

5-Wang WS, Chiou TJ, Liu JH, Fan FS, Yen CC, Tung SL, Chen PM. ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience. Jpn J Clin Oncol. 1999 Jan;29(1):33-7

6- Velasquez, W. S., P. McLaughlin, S. Tucker, et al. 1994. "ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study." J.Clin Oncol. 12(6):1169-1176.